BioSig Technologies, Inc. STEX Deferred Tax Assets In Amortization Expense Patents And Trademarks
Deferred Tax Assets In Amortization Expense Patents And Trademarks at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept STEX:DeferredTaxAssetsInAmortizationExpensePatentsAndTrademarks.
The official record: BioSig Technologies, Inc.’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s deferred tax assets in amortization expense patents and trademarks.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s deferred tax assets in amortization expense patents and trademarks?
- BioSig Technologies, Inc. (STEX) reported deferred tax assets in amortization expense patents and trademarks of $10K in Q4 2025.
- What does deferred tax assets in amortization expense patents and trademarks mean?
- This metric tracks the deferred tax benefits arising from the temporary differences between the book amortization of patents and trademarks and their tax-deductible amounts. It reflects the tax shield generated by the company's intellectual property investments over time. This is a key indicator of how intangible asset management contributes to overall tax efficiency.